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Highlights 
 Consumption of polyphenol-rich foods has demonstrated their beneficial role in the 
prevention and treatment of hypertension. 
 Curcumin, a principle polyphenolic compound of turmeric, blunts the increase in blood 
pressure and improves endothelial function and vascular remodeling in 2kidney-1clip 
renovascular hypertensive rats. 
 The mechanisms of curcumin involve an increase in nitric oxide bioavailability and 
antioxidant activity, together with a decrease in angiotensin converting enzyme, MMP-2 and 
MMP-9 levels.  
 Supplementation of curcumin in the daily diet may be useful for the prevention of 
hypertension. 
 
Abstract  
Oxidative stress plays a role in maintaining high arterial blood pressure and contributes to 
the vascular changes that lead to hypertension. Consumption of polyphenol-rich foods has 
demonstrated their beneficial role in the prevention and treatment of hypertension.  Curcumin 
(CUR), a phenolic compound present in the rhizomes of turmeric, possesses cardiovascular 
protective, anti-inflammatory and antioxidant properties.  The present study was designed to 
investigate the protective effect of CUR on 2 kidney-1clip (2K-1C)-induced hypertension, 
endothelial dysfunction, vascular remodeling and oxidative stress in male Sprague-Dawley rats. 
Sham operated or 2K-1C rats were treated with CUR at dose of 50 or 100 mg/kg/day (or 
vehicle).  After 6 weeks of treatment, CUR ameliorated hemodynamic performance in 2K-1C 
hypertensive rats (P <0.05), by reducing blood pressure, increasing hindlimb blood flow and 
decreasing hindlimb vascular resistance.  Hemodynamic restoration was associated with a 
reduction in plasma angiotensin converting enzyme level.  Endothelium-dependent 
vasorelaxation, in response to acetylcholine, of aortic rings isolated from 2K-1C hypertensive 
rats-treated with CUR was significantly increased (P <0.05).  CUR also attenuated hypertension-
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induced oxidative stress and vascular structural modifications. These effects were associated 
with elevated plasma nitrate/nitrite, upregulated eNOS expression, downregulated p47phox 
NADPH oxidase and decreased superoxide production in the vascular tissues. The overall 
findings of this study suggest the mechanisms responsible for the antihypertensive action of 
CUR in 2K-1C hypertension-induced endothelial dysfunction and vascular remodeling involve 
the improvement NO bioavailability and a reduction in oxidative stress.  
Keywords: curcumin, 2K-1C hypertension, endothelial dysfunction, nitric oxide, oxidative stress, 
vascular remodeling  
Introduction 
Hypertension is a risk factor for cardiovascular disease that is strongly associated with 
vascular dysfunction and remodeling [1-3].  In both animal models and in man, increased blood 
pressure has been associated with oxidative stress in the vascular system which, in turn, may be 
both a cause and an effect of hypertension [4]. Reactive oxygen species (ROS) play a 
physiological role in controlling endothelial function, vascular tone and cardiac function, and a 
pathophysiological role in inflammation, hypertrophy, proliferation, apoptosis, migration, 
fibrosis and angiogenesis, all of which are important processes contributing to endothelial 
dysfunction, increased contraction of vascular smooth muscle and structural remodeling causing 
increased peripheral resistance and elevated blood pressure [5-7]. 
Previous studies have demonstrated that a group of zinc-endopeptidases called matrix 
metalloproteinases (MMPs) play an important role in vascular dysfunction and remodeling in 
many types of cardiovascular disease including hypertension [8-10]. Increased MMP activation 
leads to the degradation of extracellular matrix (ECM) proteins in the blood vessels and 
promotes the migration and proliferation of vascular smooth muscle cells (VSMCs) [11].
 
ROS-
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induced MMP-2 and MMP-9 activation have been of particular interest in investigations into the 
role of vascular remodeling in hypertension [8,12-13]. 
In 2K-1C renovascular hypertension, development and maintenance of increased pressure 
is not only due to angiotensin II (Ang II)-induced vasoconstriction, released through activation of 
the renin angiotensin aldosterone system (RAAS), but is also associated with oxidative stress, 
endothelial dysfunction and vascular remodeling [14]. It has been demonstrated that excessive 
vascular NADPH oxidase expression, induced by Ang II, leads to increased superoxide 
production (O2
•-
) and contributes to endothelial nitric oxide synthase (eNOS) downregulation and 
endothelial dysfunction [14-15]. Moreover, Ang II activation in 2K-1C hypertension also 
promotes vascular remodeling as indicated by arterial wall thickening and increased MMP-2 
expression and activity [9,16]. 
Previous studies have shown that increased production of oxidants, reduced nitric oxide 
(NO) bioavailability, and reduced activity of antioxidants in the vascular system are involved in 
hypertension and cardiovascular disease [17-18]. Interestingly, treatment with tempol and the 
polyphenol-rich plant Euterpe oleracea Mart. were associated with decreased concentration of 
O2
•-
 in vascular tissues and inhibition of MMP-2-induced vascular changes in 2K-1C 
hypertension [12,19]. These results and those of many other studies in which polyphenols have 
been used in the treatment of cardiovascular disease [20] suggest that administration of 
antioxidants may be useful for the treatment of hypertension.  
Polyphenols play an important role in the maintenance of health and prevention of 
diseases. CUR (diferuloymethane) is an active ingredient of polyphenolic curcuminoids 
extracted from the rhizomes of turmeric (Curcuma longa Linn) of the Zingiberaceae family. 
CUR has been well recognized as a dietary spice for centuries and its pharmacological activity 
Page 4 of 32
5 
 
have been studied in various animal models and clinical investigations into, among others, its 
anti-inflammatory, anti-cancer, anti-diabetic, anti-hypertensive, anti-dementia and antioxidant 
properties [21-26]. Previous studies have demonstrated that CUR inhibits VSMC migration and 
proliferation and collagen synthesis in vascular cell cultures stimulated with platelet-derived 
growth factor and in the experimental model of L-NAME-induced hypertension [27-28]. 
Furthermore, recent studies have shown that CUR reduces oxidative stress in a rat model of L-
NAME hypertension [23,27]. However, there are no reports about the activity of CUR in 2K-1C 
hypertension-induced endothelial dysfunction and vascular remodeling. Therefore, the aim of 
this study was to determine whether the antioxidant CUR could reverse the hypertension, 
endothelial dysfunction, vascular structural changes and remodeling induced in 2K-1C 
hypertensive rats.  
 
Material and Methods 
Animals and Treatments  
We used the model of 2K-1C renovascular hypertension in male Sprague-Dawley rats. 
The experimental protocols were reviewed and approved by the Institutional Animal Ethics 
Committee of Khon Kaen University (AEKKU 66/2555).  The CUR (total curcuminoids > 98% 
by HPLC) was generously provided by the Research and Development Institute, The 
Government Pharmaceutical Organization (Bangkok, Thailand).   
Male Sprague-Dawley rats weighing between160 and180 g, obtained from the National 
Laboratory Animal Center, Mahidol University, Salaya (Nakornpathom, Thailand), were used in 
this study. The animals were housed at The Northeast Laboratory Animal Center (Khon Kaen 
University, Thailand) and maintained on a 12-h dark/light cycle at room temperature (25 ± 2 °C) 
with free access to standard rat chow and water.  After one week of acclimatization, rats were 
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anesthetized with pentobarbital sodium (60 mg/kg i.p.). Hypertension was induced by clipping 
the left renal artery with a silver clip (spacing, 0.2 mm). Sham-operated rats underwent the same 
surgical procedure except for the clip placement. After recovery from surgery for five days, 
animals were randomly assigned to five groups of sixteen animals in each. Ten animals were 
used for functional and biochemical evaluations and the aortas of the remaining six were fixed in 
formaldehyde and used for morphometric analysis. Groups 1 and 2 were sham operated rats that 
received propylene glycol (PG), a vehicle, at 1.5 ml/kg/day (group 1), and CUR 100 mg/kg/day 
by gavage (group 2). Groups 3-5 were clipped rats that received PG alone, CUR 50 and 100 
mg/kg/day by gavage, respectively. The doses of CUR were based on the results of a previous 
study which showed that they were sufficient to reduce blood pressure in L-NAME hypertensive 
rats [23]. Based on the use of body surface area for dose translation from rat to human [29], the 
high dose of CUR (100 mg/kg) used in this study corresponds approximately to a 950 mg dose 
for a 60 kg person. It has been reported that oral administration of CUR at dose up to 8 g/day for 
3 months did not cause any toxicity in humans [30].  
Treatment was started after the five day post-surgery recovery period and maintained for 
six weeks. Systolic blood pressure (SBP) was measured on the day before renal artery clipping 
(regarded as baseline data), five days after surgery and weekly during treatment, using tail-cuff 
plethysmography (Blood pressure analyzer, model 179; IITC Life Science Inc., CA, USA).  
Hemodynamic Measurements 
After six weeks of treatment, rats were anesthetized with pentobarbital sodium (60 
mg/kg; i.p.) and a tracheotomy was performed to allow spontaneous breathing. The femoral 
artery was cannulated and connected to a pressure transducer for monitoring blood pressure (BP) 
and heart rate (HR), using the Acqknowledge data acquisition system, (BIOPAC Systems Inc., 
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California, USA).  Hindlimb blood flow (HBF) was continuously measured by placing a cuff 
type electromagnetic flow probe (4 mm internal circumference) around the abdominal aorta, 
accessed through a laparotomy, just below the branches of renal arteries. The electromagnetic 
flow probe was connected to an electromagnetic flowmeter (Carolina Medical Electronics, North 
Carolina, USA). Hindlimb vascular resistance (HVR) was calculated from the mean arterial 
pressure (MAP) divided by HBF.  Blood samples were withdrawn from the abdominal aorta for 
assays of angiotensin converting enzyme (ACE) level and oxidative stress makers. Following the 
hemodynamic measurements, the aortas and carotid arteries were rapidly excised from the 
animals and used for vascular reactivity testing, analysis of eNOS and p47
phox
 NADPH oxidase 
expression, and O2
•− 
production. 
Vascular Reactivity Testing  
The isolated thoracic aortas were cleaned of surrounding fat and connective tissues, and 
cut into rings 4 mm in length.  The aortic rings were mounted for isometric tension recording in 
the chambers of an organ bath containing modified Krebs salt solution of the following 
concentration (mM): NaCl 119, KCl 4.7, KH2PO4 1.2, MgSO4.7H2O 1.18, Glucose 11, NaHCO3 
25 and CaCl2.2H2O 2.5, which was maintained at 37 °C, pH 7.4, and bubbled with 95% O2 and 
5% CO2.  The system was connected to an isometric force transducer and aortic responses were 
recorded on a computer using LabChart V 7.0 (PowerLab System, AD Instruments, Australia).  
A load of 1 g was initially applied to the aortic ring which was equilibrated for 90 min.  To 
examine endothelium-dependent and endothelium-independent relaxation, the cumulative 
concentration-response curves to ACh and sodium nitroprusside (SNP) ranging from 10
-9
 to 10
-5
 
M were obtained after pre-contraction with phenylephrine (1 µM).  
Assays of O2
•−
 Production, Malondialdehyde, Protein Carbonyl and Nitrate/Nitrite   
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The isolated carotid arteries were immediately placed in ice-cold Krebs salt solution and 
dissected free of fat and adhering tissue.  The arterial segments were cut into rings 4 mm in 
length and incubated with Krebs salt solution. O2
•−
 production in the carotid artery was measured 
using a lucigenin-enhanced chemiluminescence method as previously described [23].  Plasma 
malondialdehyde (MDA) was determined by measuring thiobarbituric acid reactive substances 
and oxidizing protein damage was assessed by measuring the formation of carbonyl groups, by 
reaction with 2,4-dinitrophenylhydrazine, again following a previously described method [31]. 
The level of plasma nitrate/nitrite, the end products of NO metabolism, was measured as 
previously described [23]. 
Assay of Angiotensin Converting Enzyme Activity 
The level of ACE activity in plasma was determined using the o-phthalaldehyde (OPA)-
chromogenic reaction for histidyl-leucine following a previously described method [32] with 
slight modifications. In brief, 25 μL sample of plasma and 50 μL of 15 mM Hip-His-Leu 
solution were mixed in 100 μL buffer (20 mM sodium borate and 300 mM NaCl, pH 8.3), and 
incubated at 37 °C for 30 min. Background absorbance was determined from a plasma sample 
diluted in 150 uL buffer.  The color reaction was formed by adding OPA reagent (1 mM OPA 
and 1 mM 2-meraptoethanol in buffer containing 0.1M sodium borate and 0.2 M NaOH, pH 12). 
After incubation at room temperature for 20 min, the absorbance was measured at 390 nm with a 
spectrophotometer (Ultrospec 6300 pro. Bichrom Ltd., UK). Results were calibrated according 
to a standard curve of ACE solution (15- 120 mU/mL). 
Western Blot Analysis 
Western blotting was performed on aortic homogenates in order to detect the protein 
expressions of eNOS and the p47
phox
 NADPH oxidase subunit following previously described 
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methods [23,33]. In brief, the rat thoracic aortas were homogenized in cell lysis buffer (Cell 
Signaling Technology, Inc., MA, USA) and centrifuged at 4 °C and 12000 rpm for 30 min.  The 
supernatant was collected and the protein content was analyzed by the Bradford dye-binding 
method [34].  A total of 30 µg of protein per sample was separated on 10% sodium dodecyl 
sulfate polyacrylamide gel by an electrophoresis system. The proteins were transferred 
electrophoretically onto a polyvinylidene difluoride membrane, blocked with 5% skimmed milk 
in Tris buffer saline with 0.1% Tween-20 and incubated overnight with primary antibody of 
either mouse monoclonal anti-eNOS (1:2000 dilution; BD Biosciences, CA, USA) or mouse 
monoclonal anti-p47
phox
 (1:1500 dilution; Santa Cruz Biotechnology, Indian Gulch, CA, USA). 
The membranes were repeatedly washed with TBS and incubated for 2 h at room temperature 
with the secondary antibody horseradish peroxidase goat anti-mouse IgG (1:2000 dilution; Santa 
Cruz Biotechnology). The blots were incubated in the enhanced chemiluminescent substrate 
solution (Thermo Fisher Scientific Inc., IL, USA). The intensity of specific eNOS or p47
phox
 
NADPH oxidase and β-actin bands were imaged and captured using a digital imaging system for 
quantitative imaging of gels and blots (Imagequant 400, GE Healthcare Pittsburgh, PA, USA). 
The intensity of the bands was normalized to β-actin expression from the same sample. The 
intensities were expressed as percentages of those from the aorta of normal controls. 
Morphometric Analysis and Composition of the Vascular Wall 
The animals were sacrificed by an overdose of anesthetic drug, thoracic aortas were 
cleaned of loosely adhering fibrous tissue and fixed with 4% phosphate-buffered formaldehyde.  
The vessels were cut to 5 mm in length, and embedded vertically in paraffin blocks using 
standard histological procedures. Five-m-thick sections were cut and stained with hematoxylin 
and eosin (H&E), Picrosirius Red, and Miller’s elastic stain to determine the number of VSMCs 
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and the area fraction of collagen and elastin in the aortic media layer, these being taken as 
measures of their concentration in the specimens.  Medial cross-sectional area (CSA) was 
calculated by subtracting the lumen internal area (Ai) from the external area (Ae), which was 
measured in tissue sections (×40).  The external radius (Re) and the internal radius (Ri) were 
calculated as the square root of Ae/π and Ai/π, respectively. Medial thickness (M) was calculated 
as Re minus Ri. Finally, media to lumen ratio (M/L) was calculated as the wall thickness divided 
by radius of the lumen [12]. 
The stained sections were examined with light microscopy (Nikon ECLIPSE Ni-u, Nikon 
Instruments Inc., NY, USA) and the images were captured at ×200 with a digital microscope 
camera (Nikon DS-Ri1 Camera).  Twelve images from three non-consecutive sections per 
animal were captured and used to count the number of VSMCs and measure the lumen and 
medial areas and the areas within the media of stained collagen and elastin by means of image 
analysis software (Image-Pro Plus, Media Cybernetics, MD, USA). The number of VSMCs was 
obtained by counting their nuclei of in the sections stained with H&E.  The area fraction of 
collagen or elastin in the aortic medial layer was assessed by automatically counting thresholded 
pixels stained with Picrosirius Red or Miller’s elastic staining and dividing by the total number 
of medial pixels.  All measurements were made by one observer and preliminary observations of 
intra-observer repeatability showed a coefficient of variation of less than 5% for all estimations 
of thresholded area. 
Immunohistochemistry 
To determine the amount of smooth muscle -actin (SMA) and the levels of MMP-2 and 
MMP-9  in the thoracic aortas, the de-waxed aortic sections were stained with antibodies specific 
to each: (ab5694; Abcam, for SMA, ab37150; Abcam, for MMP-2 and AB19016; Millipore, for 
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MMP-9) and the R.T.U. Vectastain ABC kit (Vector Laboratories, Inc., CA, USA) as 
recommended by the manufacture. The percentage of immunohistochemically stained SMA, 
MMP-2 or MMP-9 in the aortic wall was quantified in a similar way as collagen and elastin, by 
counting the thresholded pixels stained for SMA, MMP-2 or MMP-9 using the Image-Pro Plus 
Program.  
Assessment of the immunoreactivity for both MMP-2 and MMP-9 was quantified by 
grading the immunohistochemical staining intensity [12] into one of 3 categories: weak (+1) for 
light brown to yellow, moderate (+2) for brown, and strong (+3) for dark brown.  The level of 
MMP-2 or MMP-9 was expressed in arbitrary units, obtained by multiplying the percentage of 
area fraction and the intensity score. 
Statistical Analysis 
Results are expressed as mean ± standard error of the mean (SEM), and n refers to the 
number of animals used. Multiple comparisons between groups were made with one-way 
analysis of variance (ANOVA) followed by Student Newman–Keuls post-hoc test. A probability 
value < 0.05 was considered significant.  
 
Results 
CUR Attenuates Hypertension and Hemodynamic Disturbances  
Systolic blood pressure (SBP) was significantly increased in 2K-1C rats after renal artery 
clipping for five days and continued to increase throughout the study period (P <0.05).  When 
compared to untreated controls, CUR at the two doses used moderates the SBP in 2K-1C rats in a 
dose dependent manner (P <0.05, Fig. 1). With regard to the hemodynamic data, increased 
arterial blood pressure (systolic, diastolic and mean arterial blood pressure), decreased HBF and 
increased HVR were found in 2K-1C hypertensive rats, and this hemodynamic disturbance was 
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significantly alleviated after CUR treatment (P <0.05, Table 1). The hemodynamic statuses of 
the sham groups with or without CUR treatment were not different (Table 1), suggesting that 
CUR had no hypotensive effect on normotensive animals. Moreover, heart rates and body weight 
were not different among all groups throughout the duration of experiment (Table 1). 
CUR Improves Hypertension-Induced Endothelial Dysfunction 
To examine the effect of CUR on 2K-1C hypertension-induced endothelial dysfunction, 
aortic rings were isolated and their vascular reactivity was assessed in organ bath experiments.  
Fig. 2 shows endothelially-dependent and -independent vasorelaxation induced by ACh and SNP 
(dose range: 10
-9
 - 10
-5
 M). A significant impairment of the vascular response to ACh was found 
in the aortic rings of 2K-1C rats when compared with those isolated from the sham group (P < 
0.05, Fig. 2A). In contrast, the vasorelaxant responses to SNP were not different among the 
groups (Fig. 2B).  These results reflect endothelial dysfunction in 2K-1C hypertension. The 
impairment of endothelial vasorelaxation is confirmed by a reduction of plasma nitrate/nitrite 
concentration (P < 0.05, Table 2) and a downregulation of eNOS protein expression in the aortas 
of 2K-1C hypertensive rats (P < 0.05, Fig. 3). Treatment with CUR in a dose-dependent manner 
significantly enhanced endothelial-dependent vasorelaxation induced by ACh (P < 0.05, Fig. 
2A), but had no effect on the endothelial-independent response induced by SNP (Fig. 2B). The 
improvement of endothelial dysfunction in 2K-1C rats-treated with CUR was associated with 
increased nitrate/nitrite levels (P < 0.05, Table 2) and also upregulated eNOS expressions (P < 
0.05, Fig. 3). 
CUR Improves Hypertension-Induced Vascular Structural Changes and Remodeling 
2K-1C renovascular hypertension was associated with arterial wall hypertrophy, with 
significant increases in wall thickness, aortic medial CSA and M/L ratio after 6 weeks of 
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hypertension compared to sham operated animals (P< 0.001, Fig. 4A, B and C), whereas there 
were no significant differences in the lumen areas between the 2K-1C and the sham groups (Fig. 
4D).  Cell counting showed increased an increased number of VSMCs per medial CSA, 
suggesting medial hyperplasia in the 2K-1C group compared with the sham group (P< 0.05, Fig. 
5A). In addition, a significant increase in the number of VSMCs and the relative amounts of 
SMA, collagen and elastin in the aortic wall of 2K-1C rats were also seen (P< 0.05, Fig. 5B, C 
and D). Treatment with CUR prevented the morphological changes of the aortic wall seen in the 
2K-1C hypertensive rats (P < 0.05, Fig. 4 and 5) although only at the high dose did it 
significantly moderate the increase in SMA, elastin and collagen associated with the 2K-1C 
treatment.  It was found that the contents of SMA, collagen and elastin in the aortic media of 
sham controls were unaltered by vehicle or CUR treatment. 
 Representative immunohistochemistry photomicrographs showing MMP-2 and MMP-9 
staining in the aortas are seen in Figure 6A and B.  We found higher MMP-2 (Fig. 6A) and 
MMP-9 (Fig. 6B) levels in the aortas of 2K-1C hypertensive rats compared with sham controls 
(P < 0.05).  CUR, especially at high dose, significantly attenuated the 2K-1C hypertension-
induced increase in MMP-2 and MMP-9 levels in the aortic walls, whereas no changes in the 
MMP levels were observed in the sham + CUR group (P < 0.05, Figs. 6A and B). 
CUR Reduces ACE Activity and Oxidative Stress 
Plasma ACE levels were increased in 2K-1C rats compared to sham-operated animals (P 
< 0.05, Table 2). Treatment with CUR 100 mg/kg significantly reduced the plasma   ACE level 
(P = 0.05, Table 2). CUR did not affect plasma ACE activity in sham-operated controls.  
Increased superoxide level was found in the arteries of 2K-1C rats when compared with 
sham groups (P < 0.05, Table 2).   In parallel with these results, we found increased p47
phox 
Page 13 of 32
14 
 
NADPH oxidase subunit in the aortas from the clipped animals (P < 0.05, Fig. 7), indicating 
increased ROS production in renovascular hypertension.  Further confirming increased oxidative 
stress associated with hypertension, we found that 2K-1C rats had higher levels of plasma MDA 
and protein carbonyl than respective sham controls (P < 0.05, Table 2).  Treatment with CUR 
significantly attenuated superoxide production, MDA and protein carbonyl levels in 2K-1C rats 
(P < 0.05, Table 2), and these deleterious effects were associated with a downregulation of 
p47
phox
 NADPH oxidase subunit (Fig. 7).  
Discussion 
The main findings of this study are that treatment with CUR blunts the increase in blood 
pressure and improves endothelial dysfunction and vascular remodeling in 2K-1C renovascular 
hypertension.  These beneficial effects of CUR may contribute to the improvement of 
hemodynamic status, attenuation of vascular structural alterations, reduction in ACE and MMP 
levels, alleviation of oxidative stress, and increase in NO bioavailability.   
In agreement with previous observations [16,35], we found increased peripheral vascular 
resistance and reduced endothelium-dependent vasorelaxation-induced by ACh in 2K-1C 
hypertensive rats. These effects were evidently associated with a reduction in blood flow and 
suppression of eNOS expression, confirming the presence of endothelial dysfunction and 
reduced NO bioavailability in this hypertensive model.   
Endothelial dysfunction is often associated with pronounced oxidative stress that is due 
to, at least in part, to increase O2
●-
 from NADPH oxidase and increased degradation of NO by 
reaction with O2
●-
, thereby, reducing its bioavailability [15,18]. Thus, eNOS becomes uncoupled, 
causing O2
●-
 generation rather than NO production. NADPH oxidase is a multi-subunit 
enzymatic complex which has been shown to be one of the main sources of O2
●-
 in the vascular 
wall [36]. Upregulation of this oxidase, in particular p47
phox
 contributes to the pathogenesis of 
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oxidative stress in several animal models of hypertension [15,33,37]. In this study, increased O2
●-
 
production was associated with increased p47
phox 
expression in the vascular wall of 2K-1C rats. 
Moreover, increased oxidative stress as indicated by enhanced MDA and protein carbonyl levels 
was also found in 2K-1C hypertension.  Therefore, reduced NO bioavailability and enhanced 
oxidative stress in 2K-1C hypertension lead to less vasodilation, thereby contributing to 
endothelial dysfunction and increased vascular resistance in hypertension.  It has been reported 
that polyphenols present in fruits and vegetables are able to modulate the production of NO in 
vascular endothelium, contributing to the prevention of endothelial dysfunction [20]. We found 
that CUR, a strongly phenolic compound, restored hemodynamic status, enhanced ACh-induced 
vasodilation, upregulated eNOS expression and increased nitrate/nitrite concentration in 2K-1C 
hypertensive rats. Therefore, our findings suggest the beneficial effects of CUR on the 
improvement of vascular dysfunction and alleviation of oxidative stress in 2K-1C hypertensive 
rats. Further support for this suggestion comes from the observation that CUR treatment inhibits 
the increases in MDA and protein carbonyl levels, enhanced O2
●- 
production and p47
phox
 
expression in the arteries of 2K-1C hypertensive rats.   
Hypertension is strongly implicated in the progression of functional and structural 
alterations in the vascular system and vascular remodeling is an adaptive response to elevation of 
BP.  As we have found in this study, the process of vascular remodeling leads to increased aortic 
wall thickness which appears to be due to changes in VSMCs and ECM components [9,38].  
Consistent with this idea, we observed arterial wall hypertrophy, increased collagen and elastin 
deposition, VSMC hyperplasia and hypertrophy (as suggested by the increased area x staining-
intensity product) in the aortas of 2K-1C rats, and that these alterations are reversed by dietary 
supplementation with CUR. Since the lumen area of the aortas of 2K-1C rats did not alter, this 
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suggests that the aortic remodeling is eccentric, thus leaving the resistance of the aorta 
unchanged.   
The main function of MMPs, a family of structurally related, zinc-containing enzymes, 
has been reported to be the degradation and removal of ECM components from the tissue, 
encouraging VSMC migration and proliferation and the production of adhesion molecules 
[11,39]. The gelatinases MMP-2 and MMP-9, which cleave the basement membrane, type IV 
collagen, laminin and elastin, are the most studied MMPs in the vasculature [5]. Increased 
expression and activity of MMPs, especially MMP-2 and MMP-9 have been reported to induce 
vascular changes in animal models of hypertension [8-9,12], suggesting that MMP activation 
contributes to vascular remodeling associated with hypertension. The apparently paradoxical 
result that the scleroprotein content is raised in the hypertensive animals is associated with raised 
levels of the proteolytic enzymes MMP-2 and MMP-9 may be explained by the concept that 
hypertension-induced vascular remodeling is associated with increased MMP activity [8-
9,12,40]. Furthermore, there is evidence that MMPs are actually directly involved in the blood 
pressure increase [41-42]. Consistent with our results, increased MMP-2 expression and 
excessive collagen deposition have been found in the arterial wall of 2K-1C hypertensive rats, 
and the antioxidant therapy inhibited hypertension-induced upregulation of MMP-2 expression 
[9]. Moreover, it has been suggested that increased ROS levels in 2K-1C rats may produce 
vascular changes that are mediated by MMPs [43]. Our results support the interplay between 
MMP-2, MMP-9 and the extracellular matrix proteins during the remodeling process. However, 
more work is needed to identify their exact role. 
The expression of MMPs can be activated by Ang II [13] and ROS involved in 
preservation of MMP latency by reaction with thiol groups [44]. In fact, it has been shown that, 
Page 16 of 32
17 
 
either increased Ang II or excessive vascular O2
.-
production are implicated in vascular cell 
growth, inflammation, increased ECM deposition, vascular remodeling, promotion of MMP-2 
expression and activity, and also reduced tissue inhibitor of MMP levels in 2K-1C rats [12,45]. 
This study showed an increase in MMP-2 and MMP-9 expressions in the arterial wall of 2K-1C 
rats and these alterations are associated with increased ACE activity, thus indicating an important 
activation of the RAAS in the 2K-1C model [46]. Interestingly, we found that CUR significantly 
attenuated MMP-2 and MMP-9 expressions and reduced ACE activity in the clipped rats. 
Therefore, one of the possible mechanisms to explain the antihypertensive effect of CUR may be 
related to ACE- inhibitory activity since many ACE inhibitors inhibit MMPs. In addition, 
antioxidants can downregulate MMPs as previously shown in the 2K-1C hypertensive model 
[12],
 
suggesting a major role of ROS in MMP activity.   
Previous studies have demonstrated that CUR possesses antioxidant activity by directly 
scavenging free radicals and hydrogen donors and that it also exhibits anti-inflammatory 
properties [12,22,26]. Our previous results on L-NAME hypertensive rats demonstrated that 
CUR effectively restored NO production in association with a reduction of the over production 
of O2
•- 
in vascular tissue [23]. In addition, treatment with the antioxidant tempol and the 
polyphenol-rich plant Euterpe oleracea Mart, was associated with a downregulation of vascular 
MMP-2 expression and activity in 2K-1C hypertensive rat model [12,19]. The antioxidant effect 
of CUR is probably mediated by phenolic compounds in turmeric since recent evidence has 
demonstrated that polyphenols inhibit expression and activation of MMP-2 in VSMCs [7]. 
Increased MMP-2 expression and activity lead to less vasodilation or increased vasoconstriction, 
contributing to endothelial dysfunction and increased vascular resistance in hypertension [16,47-
48].  
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Some limitations of this study should be taken into consideration.   Firstly, 
histomorphometric analysis of scleroprotein can suffer from poor reproducibility unless suitable 
precautions are taken. With regard to the immunohistochemistry, we have optimized the 
experimental conditions to generate a strong and specific signal for the antigen of interest. The 
measurements were performed in the same batch and stained together with a positive control at 
the same time. Secondly, we note that for untreated 2K-1C animals the total area fraction of 
stained materials (elastin, collagen and the metalloproteinases) is slightly greater than 100%. We 
conclude, as others have done, that some of the components might be doubly stained. However, 
we believe that the results of the SMA staining together with the elastin and collagen data, while 
not providing absolute values of aortic composition, allow inter-group comparisons and clearly 
show how the changes in ECM proteins, VSMC and MMP content associated with hypertension 
are reduced in the animals treated with curcumin.  
In conclusion, the results of this study suggest that CUR moderates development of 
hypertension, endothelial dysfunction, vascular remodeling and oxidative stress in 2K-1C 
renovascular hypertension.  The mechanisms of these effects might involve an increase in 
antioxidant activity and NO bioavailability, together with a decrease in ACE, MMP-2 and MMP-
9 levels after CUR treatment. Our findings suggest that supplementation of CUR in the daily diet 
may be useful for the prevention of hypertension. Epidemiological and or clinical studies are 
needed to support this contention. Although the effects of dietary CUR on acute myocardial 
infarction after coronary artery bypass grafting , rheumatoid arthritis and cancer have been 
investigated [21,49-50], to our knowledge no such study into its antihypertensive effects have 
been performed to date. 
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Figure legends 
Fig. 1. Changes in systolic blood pressure before and after renal artery clipping measured by tail-
cuff plethysmography in all experimental groups. Curcumin, CUR; Systolic blood pressure, SBP. 
In this and all subsequent plots, data are means ± SEM. (n=10/group).  *P < 0.05 versus sham-
operated group, †P < 0.05 versus 2K-1C group and ‡P < 0.05 versus 2K-1C+CUR50 group. 
Fig. 2. Endothelial-dependent vasorelaxation induced by acetylcholine (A) and endothelial-
independent relaxation induced by sodium nitroprusside (B) in aortic rings pre-contracted with 
phenylephrine (1 μM). Curcumin, CUR. *P < 0.05 versus sham-operated group, †P < 0.05 
versus 2K-1C group and ‡P < 0.05 versus 2K-1C+CUR50 group. 
Fig. 3.  Effect of curcumin on eNOS protein expression in the aortas of all experimental groups.  
Height of bars represents densitometric values normalized to the corresponding β-actin. 
Curcumin, CUR. *P < 0.05 versus sham-operated group, †P < 0.05 versus 2K-1C group. 
Fig. 4. Effect of curcumin on structural modifications induced in the aortas of all experimental 
groups.  Representative photomicrographs of the aortic samples (×40) stained with H&E are 
shown together with histomorphometric data: the wall thickness (A), cross-sectional area (CSA) 
of the medial layer (B), media to lumen ratio (M/L) (C), and the lumen area (D) of the aortas. 
Curcumin, CUR. n=6/group. *P < 0.05 versus sham-operated group, †P < 0.05 versus 2K-1C 
group and ‡P < 0.05 versus 2K-1C+CUR50 group. 
Fig. 5. Effect of curcumin on vascular smooth muscle cells, smooth muscle actin, collagen and 
elastin content in the aortas of all experimental groups.  The representative photomicrographs of 
the aortic samples (×200) were stained with H&E, Picrosirius Red and Miller’s elastic stain for 
assessment of the number of vascular smooth muscle cells per cross-sectional area (panel A) and 
the area fractions of collagen (panel B), elastin (panel C) and smooth muscle actin (panel D) in 
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the aortic medial layer.  Curcumin, CUR; cross-sectional area, CSA; smooth muscle actin 
(SMA). n=6/group. *P < 0.05 versus sham-operated group, †P < 0.05 versus 2K-1C group and 
‡P < 0.05 versus 2K-1C+CUR50 group. 
Fig. 6. Effect of curcumin on MMP-2 (panel A) and MMP-9 (panel B) localization in the aortas 
of all experimental groups. Curcumin, CUR. n=6/group. *P < 0.05 versus sham-operated group, 
†P < 0.05 versus 2K-1C group and ‡P < 0.05 versus 2K-1C+CUR50 group. 
Fig. 7.  Effect of curcumin on p47
phox 
NADPH oxidase subunit in the rat aortas. Height of bars 
represents densitometric values normalized to the corresponding β-actin. Curcumin, CUR. *P < 
0.05 versus sham-operated group, †P < 0.05 versus 2K-1C group. 
 
 
 
 
Table 1 Effect of CUR on hemodynamic status in all experimental groups.  
 
Variable Sham Sham+CUR100 2K-1C 2K-1C+CUR50 2K-1C+CUR100 
BW (g) 400.1±2.6 404.4±2.1 391.4±10.0 391.8±7.5 391.5±4.9 
SBP (mmHg) 127.7±3.2 125.3±2.8 203.9±2.9
a
 177.2±7.0
a,b
 165.5±4.8
a,b
 
DBP (mmHg) 86.8±2.5 84.5±2.4 137.7±3.6
a
  119.9±6.8
a,b
 111.6±4.4
 a,b
 
MAP (mmHg) 103.4±2.8 101.3±2.5 165.6±2.8
a
  144.7±7.3
a,b
 134.3±4.6
a,b
 
HR (beats/min) 397.7±8.0 388.1±6.6 407.1±9.2 416.3±13.3 411.0±13.5 
HBF  
(ml/min/100 g 
tissue)                                      
6.0±0.4 6.1±0.4 3.5±0.4
a
 4.8±0.4
a
 5.6±0.5
a,b
 
HVR  
(mmHg/mL/min/ 
18.2±0.4 16.9±1.1 44.3±6.6
 a
 31.8±2.4
a,b
 28.1±2.6
a,b
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100 g tissue) 
Data are means ± SEM. (n=10/group), 
a
P < 0.05 versus sham-operated group, 
b
P < 0.05 versus 
2K-1C group. CUR, curcumin; BW, body weight; SBP, systolic blood pressure; DBP, diastolic 
blood pressure; MAP, mean arterial pressure; HR, heart rate; HBF, hindlimb blood flow; HVR, 
hindlimb vascular resistance. All hemodynamic variables refer to measurements made on 
anaesthetized animals 6 weeks after the start of the treatment period.  
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Table 2 Effect of CUR on the levels of oxidative stress markers, nitrate/nitrite and ACE activity 
in all experimental groups. 
Parameter Sham Sham+CUR100 2K-1C 2K-1C+CUR50 2K-1C+CUR100 
Vascular O2
.-
production 
(Count/min/mg dry weight) 
53.2±5.6 55.2±9.6 127.4±10.0
a
 91.6±6.1
a,b
 84.3±6.9
a,b
 
Plasma MDA (μM) 4.80±0.30 4.82±0.43 8.98±0.57a 6.44±0.46a,b 5.74±0.18a,b,c 
Plasma protein carbonyl 
(nmol/mg protein) 
1.18±0.04 1.16±0.12 2.33±0.24
a
 1.71±0.23
a,b
 1.51±0.11
a,b
 
Plasma nitrate/nitrite (μM) 18.6±1.8 18.7±1.5 9.3±0.9a 13.7±1.1a,b 15.5±1.7a,b 
Plasma ACE-activity 
(mU/mL) 
79.8±4.8 81.5±2.3 132.0±5.6
a
 121.9±7.6
a
 101.0±6.3
a,b,c
 
Curcumin, CUR; Malondialdehyde, MDA; Angiotensin converting enzyme, ACE. Data are 
means ± SEM. (n=10/group), 
a
P < 0.05 versus sham-operated group, 
b
P < 0.05 versus 2K-1C 
group, and 
c
P <0.05 versus 2K-1C+CUR50 group. 
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